Total Payments
$18,566
2024 Payments
$962.34
Companies
34
Transactions
218
Medicare Patients
13,920
Medicare Billing
$1.3M
Payment Breakdown by Category
Other$12,300 (66.3%)
Food & Beverage$4,856 (26.2%)
Consulting$1,000 (5.4%)
Education$345.62 (1.9%)
Travel$64.20 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,300 | 11 | 66.3% |
| Food and Beverage | $4,856 | 195 | 26.2% |
| Consulting Fee | $1,000 | 1 | 5.4% |
| Education | $345.62 | 6 | 1.9% |
| Travel and Lodging | $64.20 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $14,502 | 53 | $0 (2024) |
| GlaxoSmithKline, LLC. | $580.21 | 26 | $0 (2024) |
| GENZYME CORPORATION | $404.55 | 13 | $0 (2024) |
| Insmed, Inc. | $399.85 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $261.00 | 12 | $0 (2024) |
| United Therapeutics Corporation | $242.80 | 11 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $227.20 | 10 | $0 (2024) |
| Inspire Medical Systems, Inc. | $214.02 | 1 | $0 (2020) |
| Grifols USA, LLC | $196.64 | 8 | $0 (2024) |
| Mylan Specialty L.P. | $187.35 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $962.34 | 38 | GlaxoSmithKline, LLC. ($166.24) |
| 2023 | $1,018 | 37 | AstraZeneca Pharmaceuticals LP ($291.08) |
| 2022 | $654.54 | 30 | JAZZ PHARMACEUTICALS INC. ($93.73) |
| 2021 | $619.02 | 31 | GlaxoSmithKline, LLC. ($114.41) |
| 2020 | $702.47 | 27 | Inspire Medical Systems, Inc. ($214.02) |
| 2019 | $495.49 | 15 | GENZYME CORPORATION ($154.14) |
| 2018 | $2,566 | 11 | AstraZeneca Pharmaceuticals LP ($2,481) |
| 2017 | $11,548 | 29 | AstraZeneca Pharmaceuticals LP ($11,448) |
All Payment Transactions
218 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/07/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $95.00 | General |
| 11/07/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $34.99 | General |
| 11/07/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $31.18 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/16/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.62 | General |
| 10/01/2024 | Astellas Pharma US Inc | AmBisome (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Infectious Diseases | ||||||
| 09/19/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Cardiology | ||||||
| 09/19/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: HIV | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Immunology | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $27.28 | General |
| 07/25/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: Cardiology | ||||||
| 07/24/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $7.36 | General |
| Category: HFCWO | ||||||
| 07/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: RESPIRATORY | ||||||
| 07/03/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Respiratory | ||||||
| 06/24/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $51.98 | General |
| Category: Pulmonology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 3,420 | 5,384 | $623,154 | $329,949 |
| 2022 | 21 | 3,532 | 5,878 | $669,128 | $353,055 |
| 2021 | 22 | 3,737 | 5,759 | $650,453 | $356,597 |
| 2020 | 24 | 3,231 | 4,462 | $546,435 | $276,018 |
Total Patients
13,920
Total Services
21,483
Medicare Billing
$1.3M
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,101 | 1,873 | $280,950 | $179,831 | 64.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 196 | 196 | $58,800 | $24,586 | 41.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 696 | 1,099 | $65,940 | $22,258 | 33.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 69 | 464 | $41,760 | $21,192 | 50.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 115 | 221 | $28,730 | $13,501 | 47.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 83 | 92 | $18,400 | $12,607 | 68.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 84 | 87 | $17,400 | $8,737 | 50.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 48 | 88 | $15,840 | $8,087 | 51.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 148 | 155 | $12,400 | $6,674 | 53.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 178 | 213 | $20,874 | $6,260 | 30.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 143 | 150 | $12,000 | $6,096 | 50.8% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 174 | 259 | $7,770 | $3,661 | 47.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 27 | $8,100 | $3,617 | 44.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 11 | 96 | $7,680 | $3,595 | 46.8% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 130 | 138 | $8,280 | $3,532 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 30 | $3,040 | $1,980 | 65.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $4,200 | $1,833 | 43.6% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 18 | 18 | $9,000 | $1,333 | 14.8% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 148 | 155 | $1,550 | $357.28 | 23.1% |
| 94762 | Test to measure oxygen level in blood using ear or finger device continuously overnight | Office | 2023 | 11 | 11 | $440.00 | $213.51 | 48.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 1,146 | 2,054 | $308,100 | $193,882 | 62.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 127 | 799 | $71,910 | $38,974 | 54.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 730 | 1,124 | $67,440 | $22,610 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 175 | 175 | $52,500 | $20,365 | 38.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 64 | 140 | $25,200 | $10,892 | 43.2% |
About Dr. Jonathan Ruzi, M.D
Dr. Jonathan Ruzi, M.D is a Pulmonary Disease healthcare provider based in Scottsdale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093708935.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Ruzi, M.D has received a total of $18,566 in payments from pharmaceutical and medical device companies, with $962.34 received in 2024. These payments were reported across 218 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($12,300).
As a Medicare-enrolled provider, Ruzi has provided services to 13,920 Medicare beneficiaries, totaling 21,483 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Sleep Medicine
- Location Scottsdale, AZ
- Active Since 08/25/2005
- Last Updated 09/04/2024
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1093708935
Products in Payments
- BEVESPI AEROSPHERE (Drug) $12,869
- SYMBICORT (Drug) $1,000
- DUPIXENT (Biological) $397.80
- Arikayce (Drug) $383.61
- TRELEGY ELLIPTA (Drug) $342.65
- TEZSPIRE (Biological) $251.36
- TYVASO (Drug) $214.42
- Inspire Upper Airway Stimulation System (Device) $214.02
- XYWAV (Drug) $210.91
- Prolastin-C Liquid (Biological) $196.64
- NUCALA (Biological) $181.78
- DUPIXENT (Drug) $154.14
- OFEV (Drug) $151.41
- FASENRA (Biological) $135.21
- Yupelri (Drug) $131.88
- DORYX (Drug) $114.69
- BREZTRI (Drug) $108.10
- ALVESCO (Drug) $100.03
- OPSUMIT (Drug) $82.34
- ZERBAXA (Drug) $74.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Scottsdale
Dr. Suchitra Pilli, Md, MD
Pulmonary Disease — Payments: $34,050
Pulmonary Disease $34,050
Dr. Laszlo Vaszar, Md, MD
Pulmonary Disease — Payments: $18,971
Pulmonary Disease $18,971
Dr. Akshay Muralidhar, M.d, M.D
Pulmonary Disease — Payments: $17,691
Pulmonary Disease $17,691
Dr. David Lorber, Md, MD
Pulmonary Disease — Payments: $7,627
Pulmonary Disease $7,627
Roberto Benzo, Md, MD
Pulmonary Disease — Payments: $5,922
Pulmonary Disease $5,922
Dr. Karen Swanson, Do, DO
Pulmonary Disease — Payments: $3,800
Pulmonary Disease $3,800